MARTINSRIED, GERMANY and MUNCHEN, GERMANY -- (Marketwire) -- 05/17/12 --
MorphoSys AG / MorphoSys to Present MOR208 Preclinical Combination Therapy
Data at ASCO Meeting . Processed and transmitted by Thomson Reuters ONE. The
issuer is solely responsible for the content of this announcement.
Synergistic Effects Seen with Four Approved Treatment Options Including
Rituximab and Ofatumumab
MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX) today announced
promising pre-clinical data on its proprietary drug candidate MOR208. MOR208
(formerly XmAb(®)5574) is a potent anti-CD19 antibody with a proprietary
modification to the Fc portion that is being developed to treat B-cell
malignancies. The pre-clinical data, which will be presented at the Annual
Meeting of the American Society of Clinical Oncology (ASCO) on June 4, 2012,
demonstrate the potential for four different ... (more)
Satcon Technology Corporation® (NASDAQ CM: SATC), a leading provider of
utility-scale power conversion solutions for the renewable energy market,
today announced that it has been selected by Western Wind and Lord Electric
to supply 30 megawatts (MW) of its Equinox Prism Platform solution, a fully
integrated multi-megawatt medium voltage (MV) building block, optimized for
utility-scale PV installations.
Western Wind and Lord Electric will deploy twenty 1.5 MW Equinox Prism
Platforms to power the second largest PV plant in Puerto Rico. Equinox Prism
Platform is a turnkey utility-g... (more)
eIQnetworks, Inc., the only global provider of a unified situational
awareness solution, today announced the company has signed a strategic
reseller agreement with Namtek Corp., an IT security systems integrator, to
its roster of strategic reseller partners. Namtek's Governance, Risk
Management & Compliance (GRC) practice solves complex security challenges for
some of the most critical assets in the nation. Namtek architects and
implements technologies, policies and procedures that most effectively
protect sensitive data assets. eIQnetworks selectively forms alliances with
the ... (more)
BEVERLY, MA and TORONTO -- (Marketwire) -- 05/16/12 -- Hamilton Thorne Ltd.
(TSX VENTURE: HTL) ("Hamilton Thorne" or the "Company"), a leading provider
of precision laser devices and advanced image analysis systems for the
fertility, stem cell and developmental biology research markets, today
announced the closing of the first tranche of its previously announced
non-brokered private placement offering (the "Offering") of units ("Units")
of the Corporation. On closing, the Company issued an aggregate of 4,006,668
Units at an offering price (the "Offering Price") of CDN$0.1125 per ... (more)
ATLANTA, GA and SAN FRANCISCO, CA -- (Marketwire) -- 05/15/12 -- Connecting
the 1.3 million American adults with rheumatoid arthritis to the most
influential individuals driving the online conversation around the disease,
SharecareNow, powered by WCG, today announced "SharecareNow 10 - Rheumatoid
Arthritis." The list recognizes the patients, doctors, advocates and authors
giving daily strength, knowledge and encouragement to the rheumatoid
arthritis community online.
The release of the SharecareNow 10 - Rheumatoid Arthritis list coincides with
Arthritis Awareness Month, a nation... (more)
Subscribe to Pharmaceutical News on Ulitzer Email News Alerts
Subscribe via RSS
Ulitzer content is offered under Creative Commons "Attribution Non-Commercial No Derivatives" License.
For any reuse or distribution, you must make clear to others the license terms of this work.
The best way to do this is with a link to this web page.
Any of the above conditions can be waived if you get written permission from Ulitzer, Inc., the copyright holder.
Nothing in this license impairs or restricts the author's moral rights.